Skip to main content
Fig. 5 | BMC Cancer

Fig. 5

From: Identification of CPT2 as a prognostic biomarker by integrating the metabolism-associated gene signature in colorectal cancer

Fig. 5

CPT2 is down-regulated in colorectal cancer. A Boxplot showing the correlation of CPT2 expression in normal and READ (left) or COAD (right) samples. B Boxplot showing the correlation between CPT2 expression and tumor stage in COAD (i) and READ (ii) patients in the UALCAN database. C The representative protein expression of CPT2 in CRC and normal tissue from the Human Protein Atlas (HPA) dataset. D The expression of CPT2 was analyzed by qRT-PCR in CRC (n = 8) and normal colorectal tissues (n = 24) (i), (ii) showing the correlation between CPT2 expression and tumor stage in patients. E-F The expression of CPT2 was analyzed by qRT-PCR (E) and Western blotting (F) in NCM460 and CRC cell lines. Data are presented as mean ± SD from three independent experiments. *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us